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Although immunodominance of CD8
1 T-cell responses is a well-recognised feature of viral
infections, its role in responses to more antigenically complex pathogens is less clear. In
previous studies we have observed that CD8
1 T-cell responses to Theileria parva exhibit
different patterns of parasite strain speciﬁcity in cattle of different MHC genotypes. In the
current study, we demonstrated that animals homozygous for the A10 and A18 MHC
haplotypes have detectable responses to only one of 5 T. parva antigens. Over 60% of the
responding T cells from the A18
1 and A10
1 animals recognised deﬁned epitopes in the
Tp1 and Tp2 antigens, respectively. Comparison of T-cell receptor b chain expression
proﬁles of CD8
1 T-cell lines and CD8
1 T cells harvested ex vivo conﬁrmed that the
composition of the T-cell lines was representative of the in vivo memory CD8
1 T-cell
populations. Analysis of the Tp1 and Tp2 antigens revealed sequence polymorphism,
which was reﬂected by differential recognition by T-cell lines. In conclusion, we have
demonstrated a profound immunodominance in the CD8
1 T-cell response to T. parva,
which we propose is a major determinant of the parasite strain speciﬁcity of the response
and hence immune protection.
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Introduction
CD8
1 T-cell responses directed against class I MHC-bound
antigenic peptides play a key role in immunity against many
intracellular pathogens, including viruses, bacteria and parasites
[1]. Processing of proteins from such infectious agents can
generate a large number of distinct peptides capable of
associating with class I molecules [2, 3]. Although the T-cell
repertoire does not contain T cells speciﬁc for all of these
peptides, multiple T-cell speciﬁcities potentially capable of
responding to a range of peptides are usually present, even in
the case of the simplest RNA virus [4]. However, a characteristic
feature of CD8
1 T-cell responses to many viruses is that the
peptide epitopes display a strong dominance hierarchy, resulting
in focusing of the response on a limited number of the most
dominant epitopes [3, 5, 6]. In extreme cases, such as during
infection with HIV-1 virus in humans, most of the response can be
directed against a single epitope, a situation that favours
selection of mutations allowing escape from immune control
[7–9].
Theileria parva is one of a number of protozoan parasites,
including Trypanosoma cruzi, Toxoplasma gondii and Plasmodium
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1 T cells are
important mediators of immunity [10–13]. It is a tick-borne
parasite of cattle that infects and transforms lymphocytes causing
an acute lymphoproliferative disease, which is a major impedi-
ment to livestock production throughout a large part of eastern
and southern Africa [14]. Since T. parva does not infect labora-
tory animals, generation of information on the mechanisms of
immunity has had to rely on studies conducted in the natural
host. Treatment of infected animals to ameliorate parasite
growth, so-called ‘‘infection and treatment’’, results in recovery
from infection and acquisition of immunity [15]. Immunisation
of cattle with a single parasite strain provides effective long-
lasting immunity against the homologous strain but variable
protection against heterologous strains; typically, within a group
of immunised animals some are protected whereas others are
susceptible to challenge with a heterologous strain [16, 17].
Cattle immunised in this way generate strong CD8
1 T-cell
responses speciﬁc for parasitised lymphocytes [18, 19]. Experi-
ments involving adoptive transfer of lymphocytes between
immune and naı ¨ve identical twin calves demonstrated that
immunity could be transferred with highly enriched populations
of CD8
1 T cells [12]. Further evidence that CD8
1 T cells are key
players in immunity has come from studies of the parasite strain
speciﬁcity of the responses. CD8
1 T-cell responses of immune
cattle of different MHC genotypes generally display different
patterns of parasite strain speciﬁcity [20–22]. Importantly, the
strain speciﬁcity of the detectable CD8
1 T-cell response in
animals immunised with one parasite strain has been shown to
correlate closely with susceptibility of the animals to subsequent
challenge with a second heterologous parasite strain [17].
The genome of T. parva is predicted to encode 4034 proteins
and analyses of the transcriptome have indicated that over 60%
of these proteins are expressed by the intra-lymphocytic schizont
stage of the parasite [23, 24]. Hence, infected cells contain a
large pool of foreign proteins from which, theoretically, many
CD8
1 T-cell epitopes could be generated. In previous studies, we
have obtained evidence that MHC-related differences in domi-
nance of target antigens may be an important determinant of the
observed variation in the parasite strain speciﬁcity of the CD8
1
T-cell response in T. parva-immune animals [25]. Recently,
several T. parva target antigens have been identiﬁed by using
speciﬁc CD8
1 T-cell lines to screen expressed parasite cDNA [26,
27]. A striking feature of the results of these antigen screens was
that CD8
1 T cells from animals of different MHC genotypes
tended to identify different parasite antigens.
The present study utilised a subset of these antigens to
undertake quantitative analyses of the antigenic speciﬁcity of
CD8
1 T-cell responses in cattle immunised by infection and
treatment. The results obtained in MHC-homozygous animals
demonstrate that a large component of the response is focused on
a single dominant antigen, which differs depending on the class I
MHC type of the host. Coupled with evidence that the antigens
are polymorphic, these ﬁndings clearly demonstrate that the
observed immunodominance can have a major inﬂuence on the
parasite strain speciﬁcity of the CD8
1 T-cell response.
Results
CD8
1 T-cell responses of A10
1 and A18
1 animals are
focused on Tp1 and Tp2
Previous studies have identiﬁed several T. parva antigens, each of
which are recognised by CD8
1 T cells from immune animals of
particular MHC genotypes [26, 27]. These include Tp1 and Tp2
presented by class I gene products of the A18 and A10
haplotypes, respectively [28]. In order to determine whether
responses in A10
1 and A18
1 animals also recognise other deﬁned
antigens, CD8
1 T-cell lines from pairs of animals homozygous for
A10 and A18 were tested in a cytotoxicity assay against target
cells pulsed with pools of overlapping peptides for four or ﬁve of
the deﬁned T. parva antigens. A CD8
1 T-cell line from an
A14-homozygous animal was also included. Cell lines from the
A10
1 and A18
1 animals exhibited high levels of cytotoxicity
against target cells pulsed with Tp2 and Tp1 peptides, respec-
tively, but showed no detectable killing of targets pulsed with the
other peptide pools (Table 1). The line from the A14-homozygous
animal did not give detectable killing of any of the peptide-pulsed
targets. These results demonstrate that responses in A10
1 and
A18
1 animals are highly focused on Tp1 and Tp2, respectively, in
Table 1. Reactivity of CD8
1 T cell lines, derived from cattle immunised with T. parva, with deﬁned overlapping peptide pools representing the Tp1,
Tp2, Tp4, Tp5 and Tp8 antigens
Animal Class I MHC type Cytotoxicity (%) with peptide-pulsed targets
a)
Control Tp1 Tp2 Tp4 Tp5 Tp8
468 A18/A18 0 55 0 0 NT
b) 0
641 A18/A18 0 78 0 0 NT
b) 0
92 A10/A10 0 0 38 0 0 0
011 A10/A10 0 0 70 0 0 0
605 A14/A14 2 2 3 2 3 2
a) Cytotoxicity of CD8
1 T cell lines was examined using a 4-hour
111In release assay. Target cells consisted of autologous T. annulata-infected cells
alone (control) or incubated with 1ug/ml of pooled overlapping peptides representing the full-length amino acid sequence of each T. parva
antigen. Results are shown for assays using an effector to target ratio of 20:1.
b) NT 5 not tested
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animals of other MHC phenotype.
Responding CD8
1 T cells recognise deﬁned epitopes in
Tp1 and Tp2
In previous studies we have identiﬁed a single epitope in the Tp1
antigen (Tp1214–224) recognised by A18
1 animals and two
epitopes in Tp2 (Tp249–59 and Tp298–106) recognised by A10
1
animals [28]. CD8
1 T-cell lines from the ﬁve MHC-homozygous
animals and a further three heterozygous animals, one expressing
A10 and two expressing A18, were analysed for reactivity with
target cells pulsed with peptides representing these epitopes. The
results conﬁrmed previous ﬁndings, in that the three A10
1
animals gave detectable killing of targets pulsed with both
Tp249–59 and Tp298–106 and the four A18
1 animals killed targets
pulsed with Tp1214–224 (Table 2). The two A10-homozygous
animals exhibited stronger responses to Tp249–59 than Tp298–106,
whereas the third A10
1 animal displayed a stronger response to
Tp298–106. Again, CD8
1 T cells from the A14
1 animal did not kill
any of the peptide-pulsed targets.
Tp1 and Tp2 are highly dominant antigens in A18
1
and A10
1 animals, respectively
In order to determine what proportion of the response is directed
against the Tp1 and Tp2 antigens, clonal analyses of the CD8
1
T-cell response were undertaken in two A18-homozygous and
two A10-homozygous animals. A panel of 90 T-cell clones from
each animal was phenotyped by ﬂow cytometry to exclude
contaminant CD3
  cells and CD4
1 and gd T cells. The CD8
1
T-cell clones were tested for cytotoxicity on autologous and
allogeneic T. parva-infected target cells and on target cells pulsed
with peptides representing the Tp1 and Tp2 epitopes. Represen-
tative results of the analysis of epitope speciﬁcity are shown for
two animals in Fig. 1 and 2 and a summary of the results for all
four animals are presented in Table 3.
A majority of the clones generated from the two A10
1 animals
(64 and 95%) demonstrated detectable MHC-restricted cyto-
toxicity against the autologous T. parva-infected targets, with
variable levels of killing ranging from 7 to 79%. Lower levels of
Table 2. Reactivity of CD8
1 T cell lines, derived from cattle immunised with T. parva, with deﬁned epitopes in the Tp1 and Tp2 parasite antigens
Animal Class I MHC type Percentage cytotoxicity on target cells
a)
Autologous Allogeneic Tp1214-224 Tp249-59 Tp298-106
T. parva T. parva Peptide peptide peptide
468 A18/A18 33 1 66 4 3
641 A18/A18 27 4 100 0 0
313 A18/A31 9 1 27 0 0
663 A18/A14 7 2 37 0 0
592 A10/A10 55 3 0 68 15
011 A10/A10 51 2 0 100 47
495 A10/A14 86 1 0 3 30
605 A14/A14 54 4 0 0 0
a) CD8
1 T cell lines were tested for cytotoxicity using a 4-hour
111In release assay. Recognition of peptides was tested using autologous T. annulata-
infected target cells incubated with 1ug/mL of peptide. Results are shown for assays using an effector to target ratio of 20:1.
Figure 1. Recognition of the Tp1214–224 epitope by CD8
1 T-cell clones
derived from animal 641 (A18/A18): The clones were tested using a 4-h
111In-release assay with MHC class I A18
1, T. annulata-infected target
cells alone or incubated with 1mg/mL of Tp1214–224 peptide. Results are
shown for target cells pulsed with Tp1214–224 peptide. The level of
killing of unpulsed T. annulata-infected target cells was o1% for all
clones (data not shown).
Figure 2. Recognition of the Tp249–59 and Tp298–106 epitopes by CD8
1
T-cell clones derived from animal 1011 (A10/A10): The clones were
tested using a 4-h
111In-release assay with MHC class I A10
1,
T. annulata-infected target cells incubated with 1mg/mL of peptide.
Results are shown for targets pulsed with Tp298–106 peptide (A) or with
Tp249–59 peptide (B).
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A18
1 animals (6–33% for 641 and 6–10% for 468) and in animal
468 this was reﬂected by a much lower proportion of clones
(10%) with detectable cytotoxic activity.
Despite the variable killing of parasitised cells, over 60% of the
T-cell clones from all four animals gave signiﬁcant levels of speciﬁc
killing of peptide-pulsed targets. In each case, a large majority of
the clones was found to be speciﬁc for a single epitope. Thus, 78
and 81% of clones from the two A18
1 animals killed targets pulsed
with Tp1214–224, and 59 and 74% of clones from the A10
1 animals
reacted with Tp249–59. In the latter two animals, an additional
smaller component of the response (4 and 2%) was directed
against the second Tp2 epitope (Tp298–106). Additional experi-
ments in which selected clones were tested at a range of effector to
target ratios conﬁrmed that the variable levels of killing reﬂected
the cytotoxic activity of the clones rather than variation in the
numbers of effectors used in the assays (Fig. 3). In addition, the
ﬁnding that all clones gave signiﬁcant killing at an effector to
target ratio of 1:1 indicates that the assay employed to screen the
epitope speciﬁcity of the clones is capable of detecting most clones
with cytotoxic activity. These results provide clear evidence that
Tp1 and Tp2 are highly dominant antigens in CD8
1 T-cell
responses of A18
1 and A10
1 animals to T. parva.
In vitro CD8
1 T-cell lines are representative of the
in vivo memory population
I no r d e rt od e t e r m i n ew h e t h e rt h e s ein vitro ﬁndings reﬂect the
composition of the in vivo memory T-cell populations, we used
TCR-b chain CDR3 heteroduplex analysis to compare CD8
1 T-cell
lines with CD8
1 T cells harvested ex vivo from the same animals.
This assay can distinguish different b chain rearrangements within
each Vb subgroup, based on differential electrophoretic mobility of
heteroduplexes formed with a common carrier. Thus, expanded
clonotypes within unfractionated T-cell populations yield promi-
nent bands in polyacrylamide gels [29]. Three of the MHC-
homozygous animals used in this study were challenged on two
occasions with a lethal dose of T. parva sporozoites. Appropriate
samples were not available at the time of the ﬁrst challenge;
therefore, a CD8
1 T-cell line was derived prior to the second
challenge and compared, for each animal, with CD8
1 Tc e l l s
Table 3. Analyses of CD8
1 T cell clones derived from animals immunised with T. parva for reactivity with deﬁned epitopes in the Tp1 and Tp2
antigens
Animal (MHC type) Clones tested Numbers of positive clones and levels of cytotoxicity detected on T. parva-infected and
peptide-pulsed target cells
a)
Infected Tp1214–224 Tp249–59 Tp298–106
Positive Cytotox Positive Cytotox. Positive Cytotox. Positive Cytotox.
468 (A18/A18) 90 10 (11%) 6–10% 72 (81%) 8–100%
641 (A18/A18) 87 52 (59%) 6–33% 69 (78%) 7–100%
592 (A10/A10) 83 53 (64%) 9–74% 49 (59%) 21–96% 3 (4%) 56–99%
1011 A10/A10 89 85 (95%) 7–79% 66 (74%) 9–100% 2 (2%) 73–75%
a) CD8
1 T cell lines were tested for cytotoxicity using a 4-hour
111In release assay. Target cells consisted of autologous T. parva-infected cells
(infected) and autologous T. annulata-infected target cells incubated with 1ug/mL of the respective peptides. The number and percentage of
positive clones (positive) and the range of levels of cytotoxicity of positive clones (cytotox.) are shown for each set of clones on each target cell.
A standard cut-off of 45% speciﬁc cytotoxicity was used to deﬁne positive clones. In all assays, this was well in excess of 3 standard deviations
above the mean background release value of the respective target cells and was also well in excess of 3 standard deviations above the mean
levels of cytotoxicity obtained with MHC-mismatched T. parva-infected targets (as a control for infected targets) and unpulsed T. annulata-
infected target cells.
Figure 3. Tp2-speciﬁc CD8
1 T-cell clones show different levels of
cytolytic activity for target cells incubated with Tp249–59-peptide: Four
T-cell clones (solid symbols) were tested in a 4-h
111In-release assay
using MHC class I A10
1, T. annulata-infected target cells incubated with
1mg/mL Tp249–59 peptide. Results obtained using the clones at a range
of effector to target ratios are shown (error bars – 95% conﬁdence
intervals). Results are also shown for one of the clones tested against
the same target cells without added peptide (open squares); similar
negative results were obtained with the other clones tested on
unpulsed target cells. These assays have been repeated utilising a
narrower range of effector to target ratios (2:1 to 0.5:1) and, although
the maximal levels of cytotoxicity showed small differences, the
relative ranking of levels of cytotoxicity of the clones was similar.
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of the CD8
1 T-cell response. Figure 4 shows the results of
heteroduplex analysis for all Vb subgroups for one animal and
results for selected Vb subgroups containing abundant clonal
expansions in the other two animals are illustrated in Fig. 5. The
assay conditions employed detected only a limited number of faint
bands in resting memory CD8
1 T-cell populations, but detected
one or more prominent bands in Vb subgroups in the CD8
1 Tc e l l s
harvested ex vivo from actively responding animals. Moreover, in
each animal, comparison of the latter with in vitro-derived CD8
1
T cells revealed a remarkably similar Vb heteroduplex proﬁle.
These results demonstrate that the clonal composition of in vitro
CD8
1 T-cell cultures is similar to that of the memory population
activated in vivo following parasite challenge.
The Tp1 and Tp2 epitopes are polymorphic
In order to investigate polymorphism of the Tp1 and Tp2 antigens,
nucleotide sequences were determined for cloned PCR products of
a 435bp fragment of the Tp1 gene and the full-length Tp2 gene
from 27 T. parva-infected cell lines, derived from different parasite
isolates. Analysis of the Tp1 sequences revealed a sequence from
two isolates that differed by a single nucleotide from the Muguga
sequence, resulting in one amino acid substitution at position 10 of
the Tp1214–224 epitope. A further variant sequence obtained from
ﬁve isolates differed from Muguga by ﬁve nucleotides, two of which
resulted in amino acid substitutions at positions 10 and 11 in the
Tp1214–224 epitope (Table 4). The ability of a cloned Tp1-speciﬁc
CD8
1 T-cell line to recognise one of the parasitised cell lines that
yielded the latter sequence, infected with the Marikebuni isolate,
was tested using a cytotoxicity assay. The results, shown in Fig. 6A,
demonstrate that this line kills Muguga-infected cells but does not
kill Marikebuni-infected cells. Absence of recognition of this Tp1
allele was conﬁrmed by testing the reactivity of the same T-cell line
with COS-7 cells co-transfected with the N01301 class I heavy
chain cDNA (which encodes the A18 class I speciﬁcity) and either
the Muguga or Marikebuni Tp1 genes, using an IFN-g ELISpot
assay. A strong response was observed against Muguga Tp1, but
there was no detectable response to Marikebuni Tp1 (Fig. 6B)
The Tp2 nucleotide sequences showed more extensive
sequence divergence. Two pairs of parasite isolates yielded
sequences that had identities of only 75.4 and 75.6% with the
Muguga genome sequence. Detailed analysis of these sequences
will be reported as part of a separate study (R. Pelle et al.i n
preparation). The regions encoding the two epitopes recognised
by A10
1 animals each differed from the Muguga sequence by
seven nucleotides in Tp249–59 and 13 or 15 nucleotides in
Tp298–106, resulting in four or ﬁve amino acid substitutions in
Tp249–59 and ﬁve or six substitutions in Tp298–106 (Table 4).
Recognition of the Tp249–59 variant epitopes by two speciﬁc CD8
1
T-cell clones was examined in a cytotoxicity assay using as target
cells a T. annulata-infected cell line incubated with synthetic
Figure 4. TCR CDR3b heteroduplex analysis of bovine CD8
1 T-cell
responses to T. parva: Results obtained for each Vb subgroup are shown
for CD8
1 T cells harvested ex vivo 10 days after parasite challenge of
animal 592 (A) and with a CD8
1 T-cell line derived from the same
animal prior to challenge (B). Homoduplexes formed by re-annealing of
the carrier DNA strands are represented by a prominent band towards
the bottom of each lane. Additional more slowly migrating bands in
the upper part of the gel represent heteroduplexes formed from cDNA
of expanded clonotypes expressing Vb genes of the respective
subgroup.
Figure 5. TCR CDR3b heteroduplex analysis of bovine CD8
1 T-cell
responses to T. parva: Results are shown for CD8
1 T cells from animal
641 (A) analysed for subgroups Vb3 and Vb16, and for CD8
1 T cells from
animal 011 (B) analysed for subgroups Vb14 and Vb28. Lanes labelled Pr
represent resting CD8
1 memory T cells harvested ex vivo prior to
parasite challenge, those labelled Po represent CD8
1 T cells harvested
ex vivo 10 days following challenge and those labelled IV represent a
CD8
1 T-cell line derived immediately prior to challenge. Lanes labelled
Ca show the respective heteroduplex carriers loaded with dH20 as a
control for bands not related to T-cell populations. Homoduplexes
formed by re-annealing of the carrier DNA strands are represented by a
prominent band towards the bottom of each lane. Additional more
slowly migrating bands in the upper part of the gel represent
heteroduplexes formed from cDNA of expanded clonotypes expressing
Vb genes of the respective subgroup.
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native Tp249–59 peptide but did not kill cells pulsed with either of
the two variant peptides (Fig. 7). These results show that the Tp1
and Tp2 epitopes are polymorphic and that the allelic variants are
differentially recognised by CD8
1 T cells.
Discussion
Based on previous observations on strain speciﬁcity of CD8
1
T-cell responses to T. parva [17, 21], we have proposed that the
response in individual animals is focused on a limited number of
the antigens against which the animals are capable of responding.
The recent identiﬁcation of CD8
1 T-cell target antigens and
epitopes has allowed us to address this hypothesis. In the original
antigen screens, CD8
1 T-cell lines from animals of different class
I MHC genotypes tended to identify different antigens [26, 27].
We had also shown previously that several of the antigens,
including Tp1 and Tp2, are recognised consistently by animals of
the respective MHC genotypes [28]. However, the proportion of
the CD8
1 T-cell response directed towards the respective
antigens was not quantiﬁed and the possible presence of T cells
reactive with the other identiﬁed antigens was not examined in
detail. The results of the present study demonstrated that
responses in MHC-homozygous animals were focused on one of
the four or ﬁve antigens examined and that 460% of the
response was directed to deﬁned epitope(s) in the respective
antigens. These ﬁndings, coupled with the demonstration that the
target epitopes are polymorphic, indicate that such immunodo-
minance can have a major inﬂuence on the overall parasite strain
speciﬁcity of the CD8
1 T-cell response. Given the evidence that
strain speciﬁcity of the detectable CD8
1 T-cell response correlates
closely with susceptibility to challenge with heterologous parasite
strains [17], these results also imply that the dominant antigens
are important targets for protective immunity.
The percentages of T-cell clones found to be speciﬁc for the Tp1
and Tp2 epitopes in the present study should be viewed as minimal
estimates. Although there was considerable variation between
animals in the number of CD8
1 T-cell clones that gave detectable
killing of autologous parasitised cells, a substantial proportion of
the ‘‘non-cytolytic’’ clones in some animals gave signiﬁcant levels of
speciﬁc killing of peptide-pulsed target cells. The greater sensitivity
of the latter target cells probably relates to epitope density, since
the concentration of peptides employed is likely to have resulted in
a high level of occupancy of class I molecules on the surface of the
presenting cells. Heterogeneity in the functional activity within
epitope-speciﬁc CD8
1 T-cell populations and in responses to
different antigens is a recognised feature of CD8
1 T-cell responses
to viral pathogens [30–33]. Hence, it is likely that, in the current
study, additional clones speciﬁc for the deﬁned epitopes were
present among the clones with no detectable cytotoxic activity.
Nevertheless, the presence in three of the animals of small subsets
of clones that killed parasitised cells but not peptide-pulsed targets
indicates that these animals recognise one or more additional
undeﬁned antigens.
Since Theileria-infected cell lines express high levels of class I and
class II MHC proteins [34] and act as efﬁcient antigen-presenting
cells for stimulating parasite-speciﬁc memory T cells [20, 35], they
a r ep a r t i c u l a r l ys u i t a b l ef o rin vitro analyses of T-cell responses to the
whole parasite. However, of key relevance to the present study is
whether the composition of parasite-speciﬁc T-cell lines generated
using this in vitro system are a true representation of the memory
CD8
1 T-cell population in immunised animals. In order to address
this question, we compared the in vitro and in vivo responses using a
Table 4. Identiﬁcation of variation in Tp1 and Tp2 epitopes
Epitope Parasite Nucleotide and amino acid sequences
a)
Tp1214–224 Muguga GTA GGG TAT CCA AAG GTT AAA GAA GAA ATG CTA
VGYPKVKEEML
Kiliﬁ KL1 GTA GGG TAT CCA AAG GTT AAA GAA GAA ATT CTA
VGYPKVKEE I L
Marikebuni GTA GGG TAT CCA AAG GTT AAA GAA GAA ATT ATA
VGYPKVKEE I I
Tp249–59 Muguga AAA TCA TCA CAT GGT ATG GGA AAG GTA GGA AAA
KSSHGMGKVGK
Nyairo BR187 TTA ACA TCA CAT GGA ATG GGA AAG ATA GGT AGA
LTSHG M GKIGR
Kakuzi 498 TTA ACA TCA CAT GGT ATG GGA AGG ATA GGG AGA
LTSHG M GRIGR
Tp298–106 Muguga CAA AGC CTA GTG TGC GTA TTA ATG AAA
QSLVCVLMK
Nyairo BR187 GCA AGC ATT AAG TGT GTA TCA CAC CAT
ASIVCVSHH
Kakuzi 498 GCA AGT ATT AAG TGT GTA GCA CAA TAT
ASIKCVAQY
a) Substitutions with respect to Muguga are highlighted in grey.
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e x p r e s s i n gt h es a m eV b gene segment but different CDR3 sequences,
and thus yields a characteristic molecular proﬁle reﬂecting the
expanded TCR-b chain clonotypes within unfractionated T-cell
populations [29]. As part of the validation of the assay for analysis of
bovine T cells, we had shown that T-cell clones derived from
T. parva-speciﬁc CD8
1 T-cell lines were broadly representative of the
uncloned parent cell line [29]. In the present study, comparison of
the composition of ex vivo CD8
1 T cells, isolated at the peak of the
response to parasite challenge, with CD8
1 T-cell lines established
immediately prior to challenge revealed close similarity in hetero-
duplex proﬁles in each animal, indicating that the two populations
contain similar repertoires of expanded clonotypes. Of particular
relevance was the absence of additional sets of prominent bands in
the in vivo-derived populations, indicating that the cell lines are
representative of the in vivo memory CD8
1 T-cell population acti-
vated following parasite challenge.
Despite the antigenic complexity of protozoan parasites, the
ﬁndings of this study clearly demonstrate that parasite-speciﬁc
CD8
1 T-cell responses can display pronounced immunodomi-
nance similar to that observed for a number of viral pathogens
[5]. This represents one of the ﬁrst documented examples of
extreme immunodominance in a natural protozoan disease
model. Dominant antigens have been reported recently for CD8
1
T-cell responses to T. cruzi in a mouse model [36, 37]. Several
epitopes within a large family of trans-sialidase (Ts) proteins
were consistently recognised by C57BL/6 mice, and a class I
tetramer constructed with one of these epitopes was found to
stain approximately 30% of CD8
1 T cells harvested ex vivo during
the active response to infection. CD8
1 T cells from T. cruzi-
infected humans were also found to recognise epitopes in the Ts
proteins, although responses in individual patients appeared to
be less focused on individual dominant epitopes [36, 38]. As with
T. parva [22], the dominance pattern in mice was found to vary
depending on the infective strain of T. cruzi [36].
T. parva and T cruzi both reside free within the cytoplasm of the
host cells and hence proteins secreted by, or shed from, the surface
of the parasite have direct access to the class I antigen processing
pathway. Analysis of the transcriptome of the intra-lymphocytic
schizont stage of T. parva has detected expression of 2533 (63%)
of the 4034 genes predicted from the genome sequence [23, 24]
and 405 of the expressed genes (including Tp1 and Tp2) are
predicted to encode proteins with a signal peptide or transmem-
brane domain [24]. Evidence from studies in mice indicate that the
relative abundance of antigenic proteins and their expression
during the early stages of infection may be important factors in
determining which proteins are immunodominant [3, 39]. In this
regard, the T. cruzi epitopes that were most dominant in mice were
found to be present in multiple members of the Ts protein family
[36, 40]. Hence, it was proposed that the greater abundance of
these epitopes contributed to their dominance. By contrast, the T.
parva antigens identiﬁed to date are all encoded by unrelated
single copy genes located in different parts of the genome [26].
Figure 6. Differential recognition of Tp1 alleles, expressed by the
Muguga and Marikebuni isolates of T. parva, by a cloned parasite-
speciﬁc CD8
1 T-cell line from animal BV115 (A10/A18): (A). A 4-h
51Cr-
release cytotoxicity assay was used to test reactivity with different
parasitised cell lines. Target cells consisted of Muguga-infected cell
lines derived from the autologous animal (BV115 Tp Mug), an A18-
homozygous animal (4229 Tp Mug) and a class I MHC-mismatched
( / ) animal (BV57 Tp Mug), and a Marikebuni-infected cell line from
the autologous animal (BV115 Tp Mar). (B). An IFN-g ELISpot assay was
used to examine recognition of Tp1 cDNA expressed in COS-7 cells.
Results (error bars – 95% conﬁdence intervals) are shown for cells co-
transfected with the N01301 class I heavy chain together with Muguga
Tp2 cDNA (COS Tp2Mug), Muguga Tp1 cDNA (COS TP1Mug) or
Marikebuni Tp1 cDNA (COS Tp1Mar). Results obtained using cells
infected with T. parva (Muguga) (TpMug) as targets are shown for
comparison. Data are representative of two independent experiments.
Figure 7. Differential recognition of alleles of the Tp249–59 epitope by
two speciﬁc CD8
1 T-cell clones derived from animal 592 (A10/A10): The
clones were tested in a 4-h
111In-release cytotoxicity assay using
autologous T. annulata-infected target cells incubated with 1mg/mL
peptide. Results are shown (error bars – 95% conﬁdence intervals) for
peptides representing the Muguga Tp249–59 epitope (squares) and the
two allelic variants identiﬁed in the Nyairo BR187 (diamonds) and
Kakuzi 498 (triangles) T. parva isolates (see Table 4). Data are
representative of two independent experiments. Similar results have
also been obtained with additional T-cell clones.
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MHC backgrounds clearly indicates that multiple proteins are
available for class I antigen processing and that the dominance is
not attributable solely to differences in protein abundance. Studies
in murine model systems have implicated a number of other
factors, including afﬁnity of peptide-MHC binding, the composi-
tion of the TCR repertoire and the afﬁnity of speciﬁc TCR for the
respective peptide-MHC, in conferring competitive advantage for
preferential induction of dominant CD8
1 T-cell responses
(reviewed in [3]). In a recent immunisation trial, the observed
immunodominance of CD8
1 T-cell responses to T. parva antigens
was found to be retained in cattle immunised by a prime-boost
protocol with ﬁve of the antigens [28]. For example, six A18
1
animals all gave CD8
1 T-cell responses to Tp1 but had no
detectable responses to the other four antigens. Since the antigens
were delivered in separate vaccine constructs administered at
different sites, it was suggested that the dominance may reﬂect the
presence within the repertoire of T cells with high avidity receptors
for the respective epitopes [28].
The practical relevance of immunodominance in CD8
1 T-cell
responses to T. parva relates to its potential inﬂuence on the
parasite strain speciﬁcity of the response and cross-protection
between parasite strains. Analyses of Tp1 and Tp2 sequences
from a limited number of parasite isolates conﬁrmed that these
antigens are polymorphic and demonstrated that T-cell clones
speciﬁc for Muguga Tp1 and Tp2 failed to recognise the respec-
tive allelic variant epitopes. Further studies are underway to
examine the extent of antigenic diversity in larger samples of
parasite isolates and to determine whether the amino acid
substitutions affect MHC binding and/or TCR recognition. The
induction of highly immunodominant CD8
1 T-cell responses
against one or a few variable antigens, as observed in the present
study, clearly has the potential to result in strain-restricted
immunity. The observed differences between animals in the
patterns of parasite strain speciﬁcity of CD8
1 T-cell responses and
immunity are consistent with the ﬁnding that responses in
animals of different MHC genotypes are focused on different
dominant antigens. Such variation in speciﬁcity may reﬂect
differences in the extent and nature of polymorphism of different
dominant antigens and/or the occurrence of sexual recombina-
tion in the parasite population, which would allow independent
segregation of alleles of unlinked genes encoding CD8
1 T-cell
antigens. The capacity of T. parva to undergo sexual recombi-
nation during development in the tick vector has been demon-
strated experimentally [41, 42]. Moreover, genotyping studies of
ﬁeld isolates of T. parva have provided evidence of frequent
genetic exchange within the parasite population [43].
The wider applicability of these ﬁndings to other related
protozoan parasites is unclear. Although several of the CD8
1
T-cell epitopes in Plasmodium falciparum have been shown
to be polymorphic [44], their quantitative contribution to
parasite-speciﬁc CD8
1 T-cell responses induced by particular
parasite strains has been difﬁcult to determine. Partial sequence
data from different strains of T. cruzi indicate differences
in copy number of the dominant Ts epitopes and possible
absence of some epitopes in heterologous parasite strains [36].
Parasite strain-restricted immunity is well documented for the
poultry intestinal protozoan Eimeria maxima, and immunodo-
minance of T-cell responses has been proposed to account for the
observed variation in strain speciﬁcity of immunity in different
inbred lines of birds [45]. Hence, immunodominance of T-cell
responses may be of more general relevance as a determinant of
strain restricted immunity in protozoal infections than is
currently appreciated.
Materials and methods
Animals
Holstein–Friesian cattle carrying different combinations of four
deﬁned MHC haplotypes, expressing the A10, A14, A18 and A31
class I serological speciﬁcities, were used in this study. The class I
types of the animals were determined by a combination of
serological typing with class I-speciﬁc monoclonal antibodies
[46] and class I allele-speciﬁc PCR assays [47]. They included two
pairs of animals, deﬁned as homozygous for the A10 and A18
bovine MHC class I haplotypes. The animals were aged 18–36
months at the outset of the studies. They were reared indoors and
maintained on a ration of hay and concentrates.
Immunisation
Cattle were immunised against the T. parva Muguga stock by
infection with cryopreserved sporozoites and simultaneous
administration of a long-acting formulation of oxytetracycline
as described previously [15]. Three of the animals were
challenged with a lethal dose of sporozoites on two occasions
at approximately 18-month intervals following immunisation.
The clinical course of infection following immunisation and
challenge was followed by monitoring rectal temperature and
lymph node enlargement and microscopic examination of smears
prepared from needle aspirates of the lymph node draining the
site of infection for the presence parasitised cells.
Parasitised cell lines
Cell lines infected with T. parva and T annulata were established by
infection of PBMC in vitro with sporozoites as described previously
[48] or by culture of cells from PBMC of infected cattle [49].
Cryopreserved sporozoites of the Muguga, Marikebuni, Mariakani,
Serengeti and Kiambu 5 isolates of T. parva isolates and the C9
cloned population of T. annulata were used to establish cell lines.
Cell line isolates from naturally infected cattle were obtained from
Nyairo in Western Kenya (ten isolates), Kiliﬁ in the Coastal region in
Kenya (eight isolates) and Kakuzi in the Central Highlands of Kenya
(four isolates). Cloned derivatives of the parasitised cell lines were
obtained by limiting dilution as described previously [50].
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1 T-cell lines and clones
T. parva-speciﬁc CD8
1 T-cell-enriched cell lines and CD8
1 T-cell
clones were generated as described previously [29]. All cultures
were conducted in RPMI 1640 medium supplemented with 10%
FBS, 20mM HEPES buffer, 5 10
 5 2-mercaptoethanol, 2mM
L-glutamine and 50mg/mL gentamycin (complete culture
medium). Brieﬂy, CD8
1 T-cell-enriched lines were obtained by
stimulation of PBMC twice with gamma-irradiated autologous
T. parva-infected cells, followed by depletion of CD4 T cells and
gd T cells by antibody and complement-mediated lysis. The
remaining cells were stimulated once more with irradiated
autologous parasitised cells, in the presence of 100U/mL
recombinant human IL-2 (Chiron, Emeryville, CA., USA), and
cloned by limiting dilution 7 days later [50]. Clones were
expanded by restimulation in 48-well plates to provide sufﬁcient
cells to screen different targets for antigenic speciﬁcity.
Cell phenotyping
Cell populations were analysed by single-colour indirect immu-
noﬂourescence staining and ﬂow cytometry, using monoclonal
antibodies speciﬁc for CD3 (MM1A–IgG1), CD4 (IL-A11–IgG2a),
CD8 (IL-A51–IgG1) and gd TCR (GB21A–IgG2b), followed by
ﬂuorochrome-labelled mouse isotype-speciﬁc secondary reagents
(Southern Biotechnology Associates, Birmingham, AL, USA).
Stained cells were analysed using a FACScan cell analyser
(Becton-Dickinson, Mountain View, CA, USA).
Cytotoxicity assays
Standard 4-h release assays using
51Cr-labelled or
111In-labelled
target cells were used to measure cytotoxicity of CD8
1 T-cell lines
[50]. The antigenic speciﬁcity of CD8
1 T-cell lines was examined
using pooled synthetic peptides (16mer overlapping by 12
residues) covering the full length of ﬁve deﬁned T. parva antigens
(Tp1, Tp2, Tp4, Tp5 and Tp8) and peptides representing three
deﬁned peptides in Tp1 and Tp2 (Pepscan Systems, Lelystad, The
Netherlands). The latter consisted of an 11-mer epitope in Tp1
(Tp1214–224–VGYPKVKEEML) and 11-mer and 9-mer epitopes in
Tp2 (Tp249–59–KSSHGMGKVGK; Tp298–106 – QSLVCVLMK) [28].
Autologous T. annulata-transformed cells were incubated for
60min with 1mg/mL of peptide prior to addition of effector cells.
All assays were conducted in duplicate and controls included
T. annulata-infected target cells without added peptide. Because
of the large numbers of T-cell clones analysed, the effector T cells
used in these assays were not counted, but estimates of cell
numbers were made, based on the cell densities in the wells of
origin, to ensure that the effector to target cell ratios in the assay
were greater than 1:1. In additional experiments, selected clones
were tested at deﬁned effector to target ratios.
A standard cut-off of 45% speciﬁc cytotoxicity was used to
deﬁne positive clones. In all assays, this was well in excess of
three standard deviations above the mean background release
value of the respective target cells and was also well in excess of
three standard deviations above the mean levels of cytotoxicity
obtained with MHC-mismatched T. parva-infected and unpulsed
T. annulata-infected target cells.
Analysis of variation in Tp1 and Tp2
Total genomic DNA was prepared from T. parva-infected
lymphocytes according to Sambrook et al. [51]. A 435bp region
of the Tp1 open reading frame, containing the A18-restricted
epitope, and the full-length coding regions of Tp2 were ampliﬁed
from genomic DNA by PCR using the following primers: Tp1
forward–ATGGCCACTTCAATTGCATTTGCC; Tp1 reverse–TTCA
ATGAAATATTTATGAGCTTC; Tp2 forward–ATGAAATTGGCCGC-
CAGATTA; Tp2 reverse–CTATGAAGTGCCGGAGGCTTC. PCR
consisted of 30ng of genomic DNA and 33Zg of each primer in
a total volume of 33mL1   PCR Gold buffer (Applied
Biosystems
TM
) containing 1.5mM MgCl2, 200mM dNTP and
25U/mL AmpliTaq Gold DNA polymerase (Applied Biosys-
tems
TM
). The cycling conditions were: step 1, 951C for 11min;
step 2, 951C for 30s; step 3, 601C for 45s; step 4, 721C for 30s
(30 times from steps 2 to 4); step 5, 721C for 10min. PCR
products were sequenced directly (or following cloning into
pGEM-T Easy vector (Promega)) on an ABI 3730 capillary
sequencer (Applied Biosystems) using speciﬁc primers.
Full-length N01301 MHC class I heavy chain cDNA, ampli-
ﬁed from bovine cDNA by PCR using class I-speciﬁc forward
(ATGRGGCCGCGARCCCW) and reverse (TCAMRCTT-
TAGGAACYRTGMG) primers, and the Tp1 open reading
frame were cloned into the mammalian expression vector
pTargeT (Promega). The recombinant plasmids were co-
transfected into COS-7 cells and recognition of the expressed
products by Tp1-speciﬁc CD8
1 T-cell lines was tested by
measuring IFN-g release using an ELISpot assay as described
previously [26].
Clonal composition of T-cell populations
Cell populations enriched for CD8
1 T cells were obtained from
PBMC by complement-mediated lysis using monoclonal anti-
bodies speciﬁc for CD4 and the gd T-cell marker WC1. The clonal
composition of ex vivo-derived CD8
1 T cells and CD8
1 T-cell lines
was examined by analysis of cDNA using a TCR-b chain CDR3
heteroduplex assay as described previously [29]. Brieﬂy, tran-
scripts for different bovine Vb gene subgroups were individually
ampliﬁed using a set of 18 subgroup-speciﬁc 50 primers along
with a conserved 30 primer in the constant (Cb) region.
Heteroduplex analysis utilised 6-carboxy-ﬂuorescein (FAM)-
labelled probes for the respective Vb subgroups, incorporating
the 50 end (96–279 nucleotides) of the V gene, the CDR3 region
and 159bp of the 30 end of the constant region. Products were
analysed on 9% non-denaturing polyacrylamide gels and results
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(Biorad, Hercules, CA, USA).
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